Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2020

Veklury(Remdesivir)Gilead Sciences, Inc. logoGILD

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Gilead Sciences, Inc.

$381K

Medicare cost, 2024

Medicare drug plans spent $381,126 on Veklury (remdesivir) in 2024, for 292 prescriptions and refills filled by 164 patients. It was first approved in 2020. Spending fell 34% from 2023 to 2024. New York accounts for the most spending ($99,497, 26% of the total).

Medicare cost, 2024

$381K

-34.3% from 2023

Prescriptions

292

$1,305.22 per claim

Patients

164

117 prescribers

Total spending, 2024

$381K

$2,323.94 per patient

Questions and answers

How much does Medicare spend on Veklury?

Medicare prescription drug plans paid $381K for Veklury in 2024, for 292 prescriptions and refills to 164 patients (down 34.3% from 2023). The average cost per claim was $1,305.22.

Which state spends the most on Veklury?

New York had the highest Medicare cost for Veklury in 2024: $99K for 78 claims, followed by Oregon ($39K).

Who prescribes Veklury the most?

Gabriela Rosas-Garcia, internal medicine in Bronx, NY, had the highest Medicare cost for Veklury in 2024: 15 claims costing $14K.

Who makes Veklury?

Veklury is made by Gilead Sciences, Inc. (GILD), listed in the Medicare spending data as Gilead Sciences.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Veklury was $381K in 2024, after a high of $583K in 2023.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Veklury, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Gabriela Rosas-Garcia Bronx, NYInternal Medicine15Under 11$14K

Prescriber data by year

YearPrescribersClaimsPatientsCost
202256202129$254K
2023129444262$580K
2024117292164$381K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Gilead SciencesGILD logoGILD292$381K

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
1
RxNorm concept IDs
2284960, 2367758, 2395502, 2395504
Application numbers
NDA214787

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube